Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000040

Chief Accounting Officer acquired 18,290 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mossler Mark · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 1 in the form +18,290 19,790 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +27,430 27,430 D
Loading xslF345X05/wk-form4_1712780190.xml…